Core Scientific, Inc. current report, 05 February 2024

Full document

Core Scientific, Inc. Form 8-K Summary

Business Context and Reporting Period

Core Scientific, Inc. filed a Form 8-K dated February 5, 2024, under Item 7.01, Regulation FD Disclosure. The filing announces production and operations updates for January 2024. The underlying press release is identified as Exhibit 99.1, but its contents are not included in the provided filing text.

Financial and Operating Metrics

  • The provided text does not report revenue, net income, margins, cash flow, debt, liquidity, cryptocurrency production, hashrate, power capacity, or other operating metrics.
  • The filing text does not provide a clear value for any January 2024 production or operating measure.
  • The company’s common stock trades under the symbol CORZ on Nasdaq. Listed warrants trade under CORZW and CORZZ, with exercise prices of $6.81 and $0.01 per share, respectively.

Material Changes Versus the Prior Comparable Period

No quantitative or qualitative comparison with December 2023, January 2023, or another prior comparable period is provided in the available text. Any such changes may be described in the omitted Exhibit 99.1 press release.

Guidance, Outlook, Risks, Contingencies, and Unusual Items

  • No guidance, outlook, management commentary, risk updates, contingencies, or unusual items are included in the provided filing text.
  • Information in Item 7.01 and Exhibit 99.1 is furnished, not filed, for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except by specific reference.
  • The filing identifies the company as an emerging growth company.

Investor Verification Priorities

  1. Review Exhibit 99.1 for the January 2024 production, operating, and comparative metrics.
  2. Verify any reported bitcoin production, self-mining and hosting activity, energized capacity, hashrate, fleet utilization, and power costs against subsequent periodic filings.
  3. Check subsequent SEC filings for updated liquidity, debt, restructuring, capital requirements, and going-concern information.
  4. Confirm whether the January operational update included guidance or forward-looking statements and review the related risk disclosures.